Mycapssa 10122-0550

Generic: Octreotide

Product NDC

10122-0550

Manufacturer: Chiesi Usa, Inc.
Dosage Form: Capsule, Delayed Release
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: July 6, 2020
Listing Expires: December 31, 2026
Application: NDA208232

Need to source Mycapssa? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Octreotide	20 mg/1

Drug Class

Somatostatin Analog [EPC]Somatostatin Analog [EPC]Somatostatin Receptor Agonists [MoA]

Packaging Options(1)

10122-0550-28

4 BLISTER PACK in 1 DOSE PACK (10122-550-28) / 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK

View →